Patents by Inventor Nina Isoherranen

Nina Isoherranen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitor compounds for male contraception
    Patent number: 11548875
    Abstract: Pyrazole compounds and piperazine compounds that are inhibitors of ALDH1A1 and ALDH1A2 and methods for using the pyrazole compounds and piperazine compounds in male contraceptive compositions for preventing spermatogenesis.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: January 10, 2023
    Assignee: University of Washington
    Inventors: Alex S. Goldstein, John K. Amory, Jisun Paik, Michael Haenisch, Nina Isoherranen, Piper Treuting, Charles H. Muller
  • INHIBITOR COMPOUNDS FOR MALE CONTRACEPTION
    Publication number: 20210332030
    Abstract: Pyrazole compounds and piperazine compounds that are inhibitors of ALDH1A1 and ALDH1A2 and methods for using the pyrazole compounds and piperazine compounds in male contraceptive compositions for preventing spermatogenesis.
    Type: Application
    Filed: December 12, 2019
    Publication date: October 28, 2021
    Applicant: University of Washington
    Inventors: Alex S. Goldstein, John K. Amory, Jisun Paik, Michael Haenisch, Nina Isoherranen, Piper Treuting, Charles H. Muller
  • Specific inhibitors of cytochrome P450 26 retinoic acid hydroxylase
    Patent number: 9963439
    Abstract: The present disclosure is generally directed to compositions and methods for treating diseases that are ameliorated by the inhibition of CYP26 mediated retinoic acid metabolism. The compositions comprise compounds of formula (I).
    Type: Grant
    Filed: August 20, 2014
    Date of Patent: May 8, 2018
    Assignees: University of Washington Through Its Center For Commercialization, University of Montana
    Inventors: Philippe Diaz, Nina Isoherranen, Brian Buttrick, Nicolas Guilloteau
  • NOVEL AND SPECIFIC INHIBITORS OF CYTOCHROME P450 26 RETINOIC ACID HYDROXYLASE
    Publication number: 20160200703
    Abstract: The present disclosure is generally directed to compositions and methods for treating diseases that are ameliorated by the inhibition of CYP26 mediated retinoic acid metabolism. The compositions comprise compounds of formula (I).
    Type: Application
    Filed: August 20, 2014
    Publication date: July 14, 2016
    Applicant: UNIVERSITY OF MONTANA
    Inventors: Philippe DIAZ, Nina ISOHERRANEN, Brian BUTTRICK, Nicolas GUILLOTEAU
  • Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epiletic, neurological, and CNS activity, and method for their preparation
    Patent number: 6960687
    Abstract: New derivatives of N-Hydroxyalkyl-tetramethylcyclopropane carboxamide, pharmaceutical compositions thereof, methods for their preparation, and use thereof for the treatment of epilepsy, neurological, affective and psychotic disorders and for the treatment of pain and migraine.
    Type: Grant
    Filed: December 29, 2002
    Date of Patent: November 1, 2005
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Meir Bialer, Nina Isoherranen, Boris Yagen
  • Valproyltaurinamide derivatives as anticonvulsant amd CNS active agents
    Patent number: 6958416
    Abstract: The invention relates to derivatives of valproyltaurinamide of formula (I) in which R1 and R2 are independently hydrogen, a C1-C6-alkyl group, an arylalkyl group or an aryl group. The derivatives are especially useful for the treatment of epilepsy, affective illness, cognitive disorders, neurodegenerative disease, neuropathic pain syndrome, migraine, stroke, brain ischemia, or head trauma injury.
    Type: Grant
    Filed: March 5, 2002
    Date of Patent: October 25, 2005
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Meir Bialer, Boris Yagen, Nina Isoherranen
  • Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epiletic, neurological, and cns activity, and method for their preparation
    Publication number: 20050131069
    Abstract: New derivatives of N-Hydroxyalkyl-tetramethylcyclopropane carboxamide, pharmaceutical compositions thereof, methods for their preparation, and use thereof for the treatment of epilepsy, neurological, affective and psychotic disorders and for the treatment of pain and migraine.
    Type: Application
    Filed: December 29, 2002
    Publication date: June 16, 2005
    Applicant: YISSUM Research Development Company of the Hebrew
    Inventors: Meir Bialer, Nina Isoherranen, Boris Yagen
  • Valproyltaurinamide derivatives as anticonvulsant amd cns active agents
    Publication number: 20040242695
    Abstract: The invention relates to derivatives of valproyltaurinamide of formula (I) in which R1 and R2 are independently hydrogen, a C1-C6-alkyl group, an arylalkyl group or an aryl group. The derivatives are especially useful for the treatment of epilepsy, affective illness, cognitive disorders, neurodegenerative disease, neuropathic pain syndrome, migraine, stroke, brain ischemia, or head trauma injury.
    Type: Application
    Filed: July 14, 2004
    Publication date: December 2, 2004
    Inventors: Meir Bialer, Boris Yagen, Nina Isoherranen